Pancreatic Cancer Research

ResearcherUniversidade do PortoNo recent work listed

Meritxell Balmaña

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6587-3900; OpenAlex author ID A5044915280. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper

Papers 4

  1. Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.jprot.2019.01.006↗
  2. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues. Co-author DOI 10.1016/j.ijbiomac.2018.01.148↗
  3. Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer. Co-author DOI 10.1016/j.jprot.2015.11.006↗
  4. Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin. Co-author DOI 10.1016/j.cca.2015.01.007↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rosa Peracaula · 4 shared papers, 2015–2019 · strength 0.28
  2. Esther Llop · 3 shared papers, 2015–2018 · strength 0.18
  3. Victòria Sanz‐Nebot · 2 shared papers, 2016–2019 · strength 0.15
  4. Montserrat Mancera-Arteu · 1 shared paper, 2019 · strength 0.10
  5. Celso Albuquerque Reis · 1 shared paper, 2018 · strength 0.08
  6. Adrià Duran · 1 shared paper, 2018 · strength 0.08
  7. María José Ferri · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.